On 30 May 2026, EU Health Commissioner Olivér Várhelyi issued a statement ahead of World No Tobacco Day, calling 2026 a pivotal year for EU tobacco control policy. He reiterated the goal of a tobacco and nicotine-free generation by 2040, as outlined in Europe's Beating Cancer Plan and the Safe Hearts Plan. Várhelyi highlighted that while traditional smoking has declined, new products like nicotine pouches, e-cigarettes, and heated tobacco are creating a new generation of nicotine addicts, with over half of nicotine pouch users under 40 and nearly one in ten young people aged 15-24 having used heated tobacco products.

Várhelyi noted that in April 2026, the Commission published an evaluation report showing EU rules contributed to a significant decline in smoking and tobacco-related deaths. However, he stressed that rules must keep pace with a rapidly changing market to avoid a new wave of addiction. This month, the Commission launched a call for evidence and a public consultation on the revision of the EU Tobacco Products Directive and the Tobacco Advertising Directive. The feedback will inform a legislative proposal expected by the end of 2026.

The statement underscores the Commission's commitment to updating the regulatory framework, balancing public health protection with market realities. The revision aims to address gaps in coverage of novel nicotine products, which currently fall outside the scope of existing directives. This could impose new compliance costs on manufacturers of e-cigarettes, nicotine pouches, and heated tobacco products, potentially affecting their market access and marketing practices. For EU consumers, particularly youth, stricter rules may reduce exposure to addictive substances, but could also limit choice for adult smokers seeking reduced-harm alternatives. National authorities will face implementation challenges, including enforcement of new advertising restrictions and product standards. Public health advocates are likely to welcome the move, while industry groups may push back on the scope and timeline of the revision. The impact is moderate: the revision is a significant policy development affecting multiple stakeholders, but it follows a predictable regulatory trajectory and does not represent a paradigm shift.

← Atlas › News › Health & Lifestyle